Arcutis Biotherapeutics, Inc.
ARQT
Rank in Stocks
#4012
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Share Price
$32.29
Last synced: 2026-10-19
Market Cap
$4.06B
Change (1 day)
12.02%
Change (1 year)
54.62%
Country
US
Trade Arcutis Biotherapeutics, Inc. (ARQT)
Category
Healthcare
Stock split history for Arcutis Biotherapeutics, Inc. (ARQT)
Arcutis Biotherapeutics, Inc. stock (symbol: ARQT) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One ARQT share bought prior to Oct 20, 2026 would equal to 0 ARQT shares today.
The most recent stock split occurred on Oct 20, 2026.
One ARQT share bought prior to Oct 20, 2026 would equal to 0 ARQT shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
